To characterize the macrophages recruited and activated by highly aggressive mouse lung cancer cells, we again used a syngeneic mouse model, thus building on the results of previous studies that examined the effects of LLC/IL-1β cells and their low inflammatory counterpart LLC/neo cells expressing high and low levels of IL-1β, respectively [13], [14]. Here, IL1B is linked to lung carcinoma.